Crinetics Pharmaceuticals, Inc. Common Stock (NASDAQ: CRNX) last traded at $84.69, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from Crinetics Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Crinetics Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker CRNX. Its market capitalisation is $8.98 billion.
Valuation measures for Crinetics Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.98B |
|---|---|
| Enterprise value | $9.06B |
| Price / sales | 213.08 |
| Price / book | 7.54 |
| Beta | 0.47 |
Trailing-twelve-month figures tagged in Crinetics Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $42.16M |
|---|---|
| Net income (TTM) | -$501.61M |
| EPS (TTM) | -$5.05 |
| Operating margin | -1302.52% |
| Return on equity | -42.08% |
| Cash | $55.50M |
Range and volume for CRNX over the past 52 weeks.
| 52-week high | $84.80 |
|---|---|
| 52-week low | $29.91 |
| Volume | 1.84M |
| Average volume | 3.98M |
| Previous close | $84.69 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.